The Wayback Machine - http://web.archive.org/web/20260219120648/https://finance.yahoo.com/sectors/healthcare/
Healthcare
This sector includes biotechnology, pharmaceuticals, research services, home healthcare, hospitals, long-term-care facilities, and medical equipment and supplies. Also include pharmaceutical retailers and companies which provide health information services. Companies in this sector include AstraZeneca, Pfizer, and Roche Holding, Walgreens Boots Alliance, and Cerner Corp.
Market Cap
7.617T
Market Weight
9.74%
Industries
11
Companies
1136
Healthcare S&P 500 ^GSPC
Chart Range Bar
Loading chart for Healthcare

Day Return

Sector
0.23%
S&P 500
0.56%

YTD Return

Sector
5.27%
S&P 500
0.22%

1-Year Return

Sector
14.04%
S&P 500
12.54%

3-Year Return

Sector
21.76%
S&P 500
68.70%

5-Year Return

Sector
26.63%
S&P 500
76.14%

Note: Sector performance is calculated based on the previous closing price of all sector constituents

Industries in This Sector

Select an Industry for a Visual Breakdown

IndustryMarket WeightYTD Return
All Industries
100.00%
5.27%
Drug Manufacturers - General
42.30%
17.88%
Biotechnology
12.30%
1.98%
Medical Devices
11.44%
-0.57%
Diagnostics & Research
9.56%
-6.93%
Healthcare Plans
7.56%
-7.52%
Medical Instruments & Supplies
6.66%
-3.37%
Medical Distribution
3.27%
10.24%
Medical Care Facilities
3.22%
11.52%
Drug Manufacturers - Specialty & Generic
2.56%
1.94%
Health Information Services
1.13%
-38.59%
Pharmaceutical Retailers
0.00%
-15.73%

Note: Percentage % data on heatmap indicates Day Return

All Industries

Drug Manufacturers - General
-0.82%
Biotechnology
0.83%
Medical Devices
1.40%
Diagnostics & Research
1.52%
Healthcare Plans
0.24%
Medical Instruments & Supplies
1.84%
Medical Distribution
-0.29%
Medical Care Facilities
-0.29%
Drug Manufacturers - Specialty & Generic
0.69%
Health Information Services
4.19%
Pharmaceutical Retailers
2.00%

<= -3

-2

-1

0

1

2

>= 3

Largest Companies in This Sector

View More
Table View
Heatmap View
Name
Last Price
1Y Target Est.
Market Weight
Market Cap
Day Change %
YTD Return
Avg. Analyst Rating
1,020.56 1,202.37 13.19% 962.753B -1.50% -5.04%
Buy
244.99 231.25 8.09% 590.401B +0.68% +18.38%
Buy
228.72 246.63 5.54% 404.236B -1.78% +0.10%
Buy
121.66 124.89 4.16% 303.88B +0.07% +15.58%
Buy
288.20 364.62 3.58% 261.063B -0.31% -12.70%
Buy
379.73 350.04 2.80% 204.674B +1.71% +16.02%
Buy
113.29 133.39 2.70% 197.177B +0.92% -9.58%
Buy
513.56 666.46 2.64% 192.949B +2.39% -11.37%
Buy
152.74 155.42 2.60% 189.501B -1.63% +24.44%
Buy
500.76 611.82 2.44% 177.835B +1.50% -11.58%
Buy

Investing in the Healthcare Sector

Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds

ETF Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
157.67 40.98B 0.08% +1.85%
291.42 19.812B 0.09% +1.24%
174.76 8.534B 0.44% +3.55%
125.60 8.336B 0.35% +3.01%
100.94 4.621B 0.40% +3.63%

Mutual Fund Opportunities

View More
Name
Last Price
Net Assets
Expense Ratio
YTD Return
209.40 39.263B 0.32% +2.36%
88.29 39.263B 0.32% +2.37%
145.79 19.812B 0.09% +1.29%
134.20 15.226B 0.00% +0.74%
11.18 15.226B 0.00% +0.66%

Healthcare Research

View More

Discover the Latest Analyst and Technical Research for This Sector

  • Analyst Report: Mettler-Toledo International Inc.

    Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.

    Rating
    Price Target
     
  • Analyst Report: Molina Healthcare, Inc.

    Molina Healthcare provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states—California, New York, Texas, and Washington—account for over half of its enrollees.

    Rating
    Price Target
     
  • Analyst Report: Bausch + Lomb Corporation

    Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

    Rating
    Price Target
     
  • Analyst Report: Labcorp Holdings Inc.

    Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

    Rating
    Price Target
     

From the Community

Healthcare News